WT (WT)

Market Cap
P/E Ratio
Beta
Dividend Yield
Piotroski 6/9Beneish M -2.28 Clean

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company exhibits robust fundamental economics characterized by a high-quality earnings profile driven primarily by superior profitability rather than operational leverage or balance sheet expansion. A DuPont decomposition reveals that the 26.4% return on equity is overwhelmingly supported by a commanding net margin of 22.1%, while asset turnover remains modest at 0.33x and financial leverage sits at 3.66x, indicating earnings power stems from pricing strength rather than aggressive capital structuring. This operational efficiency is corroborated by strong quality metrics: a Piotroski F-Score of 6/9 signals solid financial health with positive trends in profitability and leverage management, while a Beneish M-Score of -2.28 suggests the absence of earnings manipulation risks often associated with inflated valuations.

Valuation analysis presents a divergence between current market pricing and intrinsic value estimates derived from discounted cash flow modeling. Although specific historical multiples are not provided for direct comparison, the DCF model implies a fair value of $33, suggesting that if this figure diverges significantly from the current trading price, the market may be mispricing future growth expectations relative to the company's ability to generate free cash flows at its current trajectory. The 15.4% year-over-year revenue growth supports an implied growth rate necessary for such a valuation, yet investors must assess whether the stock currently trades above or below this $33 anchor point to determine if premiums are being paid for sustainable expansion.

Risk assessment is tempered by mixed signals regarding insider sentiment and potential style factors. While the Piotroski score indicates financial resilience, the net selling of approximately $501,932 in insider transactions over the last 90 days introduces a cautionary note that may reflect management's view on near-term liquidity or valuation levels rather than long-term fundamentals. Without sector-specific beta data to contextualize volatility or Fama-French alpha figures to gauge style exposure, the risk-reward profile hinges largely on whether the gap between current market price and the $33 fair value can withstand potential insider-driven headwinds while maintaining its high-margin operational model.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$41$29$22
3%$49$33$24
4%$60$38$27

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $33 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
-2.28
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

54.1%
Gross Margin
22.1%
Net Margin
11.1%
ROIC
+15.4%
Revenue Growth (YoY)
+63.6%
Earnings Growth (YoY)
144.8M
Free Cash Flow
12%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

22.1%
Net Profit Margin
NI ÷ Revenue
×
0.33x
Asset Turnover
Revenue ÷ Assets
×
3.66x
Equity Multiplier
Assets ÷ Equity
=
26.4%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

2.66x
Debt / Equity
1.75x
Current Ratio
5.7x
Interest Coverage
2.8x
Net Debt / EBITDA
177.9M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-501,932
Net Selling
1
Buy Transactions
1
Sale Transactions
2026-02-25LILIEN ROBERT JARRETTSold 3/7 qtrsSale$505,200
2026-02-25PANKOPF TONIA LBuy$3,268
2026-01-27MARINOF ALEXISSold 1/7 qtrsOther45,713 shares
2026-01-27PECK WILLIAM BRADLEYOther39,996 shares
2026-01-27YATES DAVID MSold 1/7 qtrsOther37,997 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $0.15
Act: $0.16
+4.4%
Q3
✓ Beat
Est: $0.17
Act: $0.18
+2.9%
Q2
✓ Beat
Est: $0.21
Act: $0.23
+10.4%
Q1
✓ Beat
Est: $0.23
Act: $0.29
+23.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

Forward P/E
PEG Ratio
Price/Book
Avg Volume
52W High
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$33M
Tracked Passive Exposure
4
ETFs Holding WT
0.08%
Avg Weight in ETFs
$43B
Total ETF AUM

When investors buy or sell ETFs like SLYG or SPSM, the fund manager is mechanically forced to buy or sell WT shares regardless of WT's individual fundamentals. We estimate $33M of passive capital is structurally linked to WT through 4 tracked ETFs. Passive flows have a limited but growing influence on WT's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 4 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in WT to visualize passive redemption contagion across ETFs and collateral stocks.

WT Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
WTEpicenterSPSMETFVFHETFSPTMETFJPMHigh RiskBRK.BUnknownNVDALow RiskAAPLLow RiskMALow Risk
WT Price Drop (%)0

If WT (WT) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies JPMorgan Chase & Co. (JPM) as the most exposed collateral stock, sharing 1 ETFs with WT. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 4 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

WT Ownership Dynamics

Ticker
WT

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

WT Capital Efficiency

How efficiently does WT convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$145M
EBITDA
$178M
FCF Conversion
81%
Reinvestment Rate
19%
81% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

WT converts 81% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1453,642$19.49$1.0M
2026-05-13302,991$18.72$5.7M
2026-05-1111$19.10$210.1
2026-05-088,923$18.72$167,038.56
2026-05-075,824$19.06$111,005.44
2026-04-2010,000$17.46$174,600
2026-04-1454,200$16.38$887,796
2026-04-13537,165$15.84$8.5M
2026-04-10216,778$15.85$3.4M
2026-04-0913,720$15.56$213,483.2
2026-04-089,622$15.10$145,292.2
2026-04-07128,450$14.94$1.9M
2026-04-0661,013$14.45$881,637.85
2026-04-01300$14.56$4,368
2026-03-3113,412$13.92$186,695.04
2026-03-2760,272$14.55$876,957.6
2026-03-2034,803$13.86$482,369.58
2026-03-1984,282$14.26$1.2M
2026-03-18675$15.05$10,158.75
2026-03-179,637$14.84$143,013.08
2026-03-16966$15.26$14,741.16
2026-03-122,588$15.67$40,553.96
2026-03-09165$16.62$2,742.3
2026-03-0342,050$17.52$736,716
2026-03-026,185$17.11$105,825.35
2026-02-2777,412$17.37$1.3M
2026-02-2637,533$17.31$649,696.23
2026-02-2559,494$16.69$992,954.86
2026-02-2391,087$16.38$1.5M
2026-02-203,528$16.51$58,247.28

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare WT to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.